Key Highlights
- 8.74% is the indicated pre-market decline for 22nd Century Group, Inc (NASDAQ:XXII) on November 17, 2026, taking the price to USD 0.4501 from a calculated prior close of USD 0.4932, a calculated move of -USD 0.0431.
- 66% is the Revenue growth the company reported in preliminary third-quarter 2026 results released October 22, 2026, with revenue of USD 4.8 million and Gross Profit of USD 0.4 million for the reduced-nicotine tobacco business.
- 6.06 million is the USD cash balance at June 30, 2026, down from USD 9.55 million at March 31, 2026, while total Debt rose to USD 1.75 million from USD 1.32 million over the same period.
- 161% is the same-store unit sales growth the company announced on October 15, 2026 for its Pinnacle VLN and Pinnacle Pure products, followed on October 26, 2026 by an expansion of Pinnacle Pure to 6 SKUs.
What Moved 22nd Century Group, Inc (NASDAQ:XXII) in Pre-Market Trading on November 17, 2026 (-USD 0.0431, -8.74%)
The indicated pre-market price for 22nd Century Group, Inc (NASDAQ:XXII) is USD 0.4501 on November 17, 2026, a pre-market move of -8.74%. The calculated prior close is USD 0.4932 (USD 0.4501 divided by 0.9126), and the calculated USD move is -USD 0.0431. Published market data showed the stock at USD 0.1037 on October 27, 2026, so the indicated price is well above that level. Pre-market Volume and a corroborated market Capitalization were not found, and early sessions are typically thin.
The Rationale: No Single Catalyst Identified After the Third-Quarter Update for 22nd Century Group, Inc (NASDAQ:XXII)
No catalyst for the November 17, 2026 decline was identified in published coverage. As general context, a low-priced stock with a history of large price swings can give back gains quickly, and pre-market illiquidity widens moves. Recent company news included preliminary third-quarter results on October 22, 2026, same-store unit sales growth announced October 15, 2026, a statement on September 28, 2026 positioning its reduced-nicotine platform for France's nicotine-reduction initiative, and a September 24, 2026 call for the FDA to enact a reduced nicotine content standard.
Valuation, Liquidity and Risks for 22nd Century Group, Inc (NASDAQ:XXII)
22nd Century Group was founded in 1998, has 32 employees and makes reduced-nicotine tobacco products in the United States, including very low nicotine cigarettes, along with contract Manufacturing for third-party brands. At June 30, 2026, cash was USD 6.06 million, total debt was USD 1.75 million, total Assets were USD 26.17 million and shareholders' Equity was USD 18.64 million. Gross profit of USD 0.4 million on USD 4.8 million of preliminary third-quarter revenue shows thin margins. The share price history includes extreme adjustments, so per-share comparisons across periods can mislead, and the stock carries low-priced stock, dilution and listing risk.
Where Things Stand
22nd Century Group, Inc (NASDAQ:XXII) is indicated down 8.74% in pre-market trading on November 17, 2026, at USD 0.4501, a calculated decline of USD 0.0431 from a prior close of USD 0.4932. No specific catalyst was identified in published coverage. Preliminary third-quarter revenue was USD 4.8 million, up 66%, with gross profit of USD 0.4 million, while cash was USD 6.06 million at June 30, 2026 against USD 1.75 million of debt. Cash burn, thin margins and low-priced stock Volatility remain central risks, and pre-market moves can reverse quickly in thin trading. This article is informational and is not Investment advice.






Please wait processing your request...